Evidence map›Paper›PMID 26169410›Full record

ArticleAntimicrobial agents and chemotherapy2015

Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione.

Kevin Chiem, Brooke A Fuentes, David L Lin, Tung Tran, Alexis Jackson, Maria S Ramirez, Marcelo E Tolmasky

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. The promise of copper ionophores as antimicrobials.Current opinion in microbiology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Inducible Resistance to Amikacin inInfection and drug resistance · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Aminoglycoside 6'-Antibiotics (Basel, Switzerland) · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kevin ChiemCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
Brooke A FuentesCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
David L LinCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
Tung TranCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
Alexis JacksonCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
Maria S RamirezCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA.
Marcelo E TolmaskyCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, California, USA mtolmasky@fullerton.edu.
California State University, Fullerton · US

Funding

DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGYR15AI047115 · NIAID · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2000 to 2022
$1.8M
NIAID NIH HHS 2R15AI047115-04NIAID NIH HHS R15 AI047115
6 · The paper itself

Abstract

The in vitro activity of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] was inhibited by CuCl2 with a 50% inhibitory concentration (IC50) of 2.8 μM. The growth of an amikacin-resistant Klebsiella pneumoniae strain isolated from a neonate with meningitis was inhibited when amikacin was supplemented by the addition of Zn(2+) or Cu(2+) in complex with the ionophore pyrithione. Coordination complexes between cations and ionophores could be developed for their use, in combination with aminoglycosides, to treat resistant infections.

Indexed as

AcetyltransferasesAmikacinAminoglycosidesAnti-Bacterial AgentsKlebsiella pneumoniaeMicrobial Sensitivity TestsOrganometallic CompoundsPyridinesZincAcetyltransferasesAmikacinaminoglycoside N(6')-acetyltransferaseAminoglycosidesAnti-Bacterial Agentscopper pyrithioneOrganometallic CompoundsPyridinesZinc

Identifiers

PMID26169410
PMCPMC4538519
OpenAlexW1790563411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.